CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency department

Abstract Introduction Our purpose was to compare the safety and efficacy of food and drug administration (FDA) recommended dosing of IV nicardipine versus IV labetalol for the management of acute hypertension. Methods Multicenter randomized clinical trial. Eligible patients had 2 systolic blood pres...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: W. Frank Peacock, Joseph Varón, Brigitte M. Baumann, Pierre Borczuk, Chad Cannon, Abhinav Chandra, David Cline, Deborah B. Diercks, Brian Hiestand, Amy P. Hsu, P. Jois-Bilowich, Brian Kaminski, Philip Levy, Richard M. Nowak, Jon W. Schrock
Format: Artigo
Idioma:anglès
Publicat: 2011
Accés en línia:https://doi.org/10.1186/cc10289
https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc10289
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!